TGA Approval

VITRAKVI larotrectinib (as sulfate) 20 mg/mL bottle (388084)

ARTG ID

388084

ARTG Name

VITRAKVI larotrectinib (as sulfate) 20 mg/mL bottle

Sponsor

Bayer Australia Ltd

ARTG Date

September 20, 2022

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered - Prescription

Sponsor Information

Sponsor Name

Sponsor Item Name

BAYER AUSTRALIA LTD

https://medical-cdn.nocode.com/drug_tga/74e3eb8086e1935a5eeaa55dc9f05654.pdf

https://medical-cdn.nocode.com/drug_tga/91c2ee80844939c64859343d93ff25a3.pdf

Ingredient Name

larotrectinib sulfate

Empowering clinical research with data-driven insights and AI-powered tools.

VITRAKVI larotrectinib (as sulfate) 20 mg/mL bottle (388084) - TGA 批准文号 | MedPath